Portal Instruments, Inc. news
Portal Instruments is pleased to announce the appointment of Dr. Veena Rao, PhD, as Chief Business Officer, effective December 5th, 2022. Dr. Rao will lead the identification, evaluation, and negotiation of partnership opportunities for Portal. In addition, Dr. Rao, in close collaboration with the CEO and cross-functional team, will guide the company’s short and long-term commercial strategy. She will report directly to the company CEO, Dr. Patrick Anquetil.
Gerresheimer AG is expanding its portfolio of highly-innovative platform technologies for drug delivery. Gerresheimer, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, today announced an investment into US-based Portal Instruments, a developer of a next-generation needle-free drug delivery technology. Together, the partners aim at transforming the administration of injectable medicines and improving the patient’s experi
August is National Psoriasis Awareness Month. To bring awareness to the illness and injection challenges, we spoke with Grace Vasher and learned about her personal journey with Psoriasis. Grace is a nineteen year old college student studying elementary education.
“Psoriasis is something I have experienced from a very young age. I was of
There are self-driving cars, 5G smartphones, and now planes that travel from New York to London in 3.5 hours. The world we live in and the technology we use are rapidly evolving. But, when it comes to drug delivery methods, the 160-year old technology behind the needle and syringe has yet to catch wind of any radical transformation. With cutting-edge technology from MIT, Portal Instruments aims to transform how injections are given while improving the experience for patients on life-cha
The National Transgender Discrimination Survey Report on Health and Health Care recorded at least 80% of transgender people have either taken gender-affirming hormone therapy (GAHT) or want to take GAHT at some point.¹ We sat down to learn from Joelle Jacoski about the drug delivery challenges of taking GAHT.